Birgitte Volck
Board Member
Biochemistry
Wilson Therapeutics
Sweden
Biography
Education: MD and PhD Copenhagen University. Other current assignments: Senior Vice President, Head of R&D Rare Disease at GlaxoSmithKline. Board member of TFS Trial Form Support International AB and Ascendis Pharma A/S. Previous assignments (last five years): Chief Medical Officer Swedish Orphan Biovitrum AB. Position: Independent of the Company, executive management and major shareholders. Holdings in the Company: 20,100 performance shares Board LTIP 2017.
Research Interest
Biochemistry, Pharmacology
